Volume 11, Number 6 (Aug 2020)

ASCO20 Virtual Scientific Program: Takeaways for the Advanced Practitioner

Gastrointestinal Cancers: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Using coverage from The ASCO Post, Nina N. Grenon, DNP, AGCNP-BC, AOCN®, of Dana-Farber Cancer Institute, evaluates findings from two phase III trials, reviews takeaways from the final results of the IDEA study, and discusses what was le...

Prostate Cancer: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Morgane C. Diven, PharmD, BCOP, of Phoenix VA Health Care System, breaks down abstract summaries published in The ASCO Post on a novel target, imaging agent, and androgen-deprivation therapy for prostate cancer, along with their implicat...

Genitourinary (Non-Prostate) Cancers: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Following coverage from The ASCO Post, Jeannette Hammond, PA-C, of Seattle Cancer Care Alliance, comments on the results of practice-changing studies on novel therapies in urothelial cancer and renal cell carcinoma.

Gynecologic Cancers: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Following coverage by The ASCO Post, Laura Doherty, FNP-BC, AOCNP®, of Women & Infants Hospital of Rhode Island, interprets findings from major gynecologic oncology abstracts featured in The ASCO Post and considers takeaways for adva...

Breast Cancer: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Paula Anastasia, RN, MN, AOCN®, of UCLA Health Medical Center, and Wendy H. Vogel, MSN, FNP, AOCNP®, of Harborside, discuss results from studies evaluating therapies in women with de novo metastatic breast cancer and HER2-positive breast...

Thoracic Cancers: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, of MD Anderson Cancer Center, reviews the major abstracts in thoracic cancers from the ASCO20 Virtual Scientific Program using coverage by The ASCO Post and offers considerations for advanced ...

Melanoma: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

With coverage by The ASCO Post, Lisa Kottschade, APRN, MSN, CNP, of Mayo Clinic, reviews clinical data on which patients with metastatic melanoma should receive combination therapy vs. single-agent PD-1 up front, and what to do at the ti...

Other Solid Cancers: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, of MD Anderson Cancer Center, evaluates a study showing activity by pralsetinib in patients with a variety of tumors harboring RET gene fusions, and Abby Fuoto, DNP, ANP-BC, AOCNP®, ACHPN, of ...

Hematologic Malignancies: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Amy Pierre, MSN, ANP-BC, of Memorial Sloan Kettering Cancer Center, P. Andrew Allred, MS, PA-C, of Banner MD Anderson Cancer Center, and Allyson Price, PA-C, of MD Anderson Cancer Center, provide expert insights for advanced practitioner...

Issues in Oncology: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Josh Epworth, ARNP, of Seattle Cancer Care Alliance/University of Washington Medical Center, distills three influential abstracts from the ASCO virtual meeting and reflects on how advanced practitioners can use the findings to improve th...